SCHEMBL1390334

SCHEMBL1390334

Cc1ccccc1C(CC(=O)c1ccc[n+]([O-])c1)c1ccc(Br)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GPR84 Q9NQS5 2/20 0.35
PTGFR P43088 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
CTSA P10619 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
AHR P35869 1/20 0.33
PDPK1 O15530 1/20 0.33
MGAM O43451 2/20 0.33
GAA P10253 2/20 0.33
SI P14410 2/20 0.33
MGAM2 Q2M2H8 2/20 0.33
APLNR P35414 2/20 0.33
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370657 0.86 L3MBTL1 (0.41) MEN1KMT2AGPR84L3MBTL1CTSA
SCHEMBL369497 0.84 MGAM (0.47) MEN1KMT2AGPR84L3MBTL1POLB
SCHEMBL1390412 0.82 MGAM (0.41) MEN1KMT2AGPR84POLBHTT
SCHEMBL370009 0.82 MEN1 (0.36) MEN1KMT2AGPR84L3MBTL1NPSR1
SCHEMBL370450 0.80 GAA (0.47) MEN1KMT2AGPR84L3MBTL1NPSR1
SCHEMBL371142 0.80 MGAM (0.41) MEN1KMT2AGPR84L3MBTL1AHR
SCHEMBL370273 0.79 MGAM (0.37) KMT2APTGFRL3MBTL1CTSAMGAM
SCHEMBL370667 0.78 KMT2A (0.46) MEN1KMT2AGPR84POLBMGAM
SCHEMBL371379 0.78 GPBAR1 (0.39) PTGFRCTSAPOLBPDPK1NPC1
SCHEMBL370541 0.76 CNR1 (0.36) MEN1KMT2AGPR84POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 MEN1 1315/4885KMT2A 3981/4885GPR84 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.